Position in STRO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$449,660
+$448,503 QoQ
Shares Held
13,544
+13444.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 97 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. STRO ranks #191 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in STRO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $449,660 | 13,544 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $1,157 | 100 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $492 | 693 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $31,937 | 49,134 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $97,037 | 52,738 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $146,260 | 42,272 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $122,640 | 41,857 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $154,623 | 27,367 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $99,412 | 23,173 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $67,723 | 19,517 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $128,223 | 27,575 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $231,752 | 50,163 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $45,975 | 5,690 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,314 | 1,318 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,336 | 2,752 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $313,254 | 38,109 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $776,986 | 52,217 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,131,168 | 112,820 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,605,739 | 140,169 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,271,406 | 143,735 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,362,213 | 62,746 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $459,152 | 45,687 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $238,036 | 30,675 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $218,912 | 21,462 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||